Therefore, in order to reduce this, minor incisions must be taken in place of the cornea which, as previously mentioned, is forming in the shape of a curve, which will flatten the turn to a little extent, thereby allowing the cornea to be rounder and uniform. By performing astigmatism in order to correct the removal of cataract the requirement of prescription glasses and reading glasses post cataract extraction is avoided and ensures better vision for patients. Astigmatism rates increase dramatically from 14.3% in the under 15-year-old age group to 67.2% in the age group of over 65-years old. Since astigmatism affects the population of people over 65-years old which are more likely to suffer from phacolytic glaucoma it is an effective procedure which can take place during the cataract surgery used to correct phacolytic glaucoma and improve the quality of life of sufferers. Epidemiology
The youngest patient found to be diagnosed with Phacolytic Glaucoma was 35 years of age, which thereby highlights its significant prevalence in senior patients. Moreover, Phacolytic Glaucoma is more likely seen in underdeveloped countries as a result of the lack of access to ophthalmologic care. When being faced with Phacolytic Glaucoma most cases ameliorate when the cataract is extracted thereby enhancing vision. On the other hand, this disease is less prevalent in developed countries such as Australia and the United States, due to a greater access to health care and earlier cataract surgery. == References ==
List of side effects
Cardiovascular: Myocardial infarction; stroke; heart block; arrhythmias; hypotension, particularly orthostatic hypotension; hypertension; tachycardia; palpitation.Psychiatric: Confusional states (especially in the elderly) with hallucinations, disorientation, delusions, anxiety, restlessness, agitation; hypomania; exacerbation of psychosis; insomnia, panic, and nightmares.Neurological: Seizures; incoordination; ataxia; tremors; peripheral neuropathy; numbness, tingling, and paresthesias of extremities; extrapyramidal symptoms; drowsiness; dizziness; weakness and fatigue; headache; syndrome of inappropriate ADH (antidiuretic hormone) secretion; tinnitus; alteration in EEG patterns.Anticholinergic: Paralytic ileus; hyperpyrexia; urinary retention, delayed micturition, dilatation of the urinary tract; constipation; blurred vision, disturbance of accommodation, increased intraocular pressure, mydriasis; dry mouth and rarely associated sublingual adentitis.Allergic: Drug fever; petechiae, skin rash, urticaria, itching, photosensitization (avoid excessive exposure to sunlight); edema (general, or of face and tongue).Hematologic: Agranulocytosis; bone marrow depression; leukopenia;thrombocytopenia; purpura; eosinophilia.Gastrointestinal: Nausea and vomiting; anorexia; epigastric distress; diarrhea; peculiar taste; stomatitis; abdominal cramps; black tongue.Endocrine: Impotence, increased or decreased libido: gynecomastia in the male; breast enlargement and galactorrhea in the female; testicular swelling; elevation or depression of blood sugar levels.Other: Jaundice (simulating obstructive); altered liver function; parotid swelling; alopecia; flushing; weight gain or loss; urinary frequency, nocturia; perspiration. Overdose
Deaths may occur from overdose with this class of drugs. Multiple drug ingestion (including alcohol) is common in deliberate TCA overdose. As management of overdose is complex and changing, it is recommended that the physician contact a poison control center for current information on treatment.